iLidRx pods being used in University of Michigan Cancer Center study - News Details

iRxReminder in the News

iLidRx pods being used in University of Michigan Cancer Center study

iLidRx pods being used in University of Michigan Cancer Center study
Feb 3, 2017, 12:00 am

Principal investigator Dr. Shawna Kraft, and co-investigators Drs. Mike Dorsch and Karen Farris, are utilizing the iRxCapture Pro and iLidRx to improve the adherence of oral chemotherapy medications in a study funded by the Hematology Oncology Pharmacy Association. The study is being conducted by The University of Michigan College of Pharmacy at the University of Michigan Cancer Center.